![Barclays: Risks for Tech correction are mounting despite strong fundamentals](https://i-invdn-com.investing.com/news/SP500StandardandPoors500Index_150x108_S_1657544297.jpg)
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1043 | 1031 | 1064 | 1213 | 1296 | 1648 |
Fund Return | 4.3% | 3.07% | 6.38% | 6.66% | 5.33% | 5.12% |
Place in category | 1728 | 1691 | 1616 | 822 | 1110 | 626 |
% in Category | 81 | 80 | 83 | 47 | 74 | 67 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.88 | 978.2 | -0.23% | |
HSBC | GB0005405286 | 3.61 | 685.20 | +0.32% | |
AstraZeneca | GB0009895292 | 3.52 | 12,370.0 | -0.47% | |
Novartis | CH0012005267 | 3.14 | 92.85 | -0.74% | |
Kion Group AG | DE000KGX8881 | 2.34 | 40.61 | +0.74% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Sell | BUY | Strong Buy |
Summary | Sell | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review